| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Keiko Tanaka, Takeshi Kezuka, Hitoshi Ishikawa, Masami Tanaka, Kenji Sakimura, Manabu Abe, Meiko Kawamur. Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review. International journal of molecular sciences. vol 24. issue 17. 2023-09-09. PMID:37686172. |
pathogenesis, clinical features, and treatment of patients with myelin oligodendrocyte glycoprotein (mog) autoantibody-associated disorders focusing on optic neuritis with consideration of autoantibody-binding sites: a review. |
2023-09-09 |
2023-10-07 |
mouse |
| Keiko Tanaka, Takeshi Kezuka, Hitoshi Ishikawa, Masami Tanaka, Kenji Sakimura, Manabu Abe, Meiko Kawamur. Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review. International journal of molecular sciences. vol 24. issue 17. 2023-09-09. PMID:37686172. |
although there is a substantial amount of data on the clinical characteristics, diagnostic criteria, and pathogenesis of myelin oligodendrocyte glycoprotein (mog) autoantibody-associated disease (mogad), there is still uncertainty regarding the mog protein function and the pathogenicity of anti-mog autoantibodies in this disease. |
2023-09-09 |
2023-10-07 |
mouse |
| Rui Zhang, Li Wang, Yongli Tao, Xiaofeng Zhang, Kai Liu, Bo Song, Yuming X. The case report of MOG and NMDAR IgG double positive encephalitis treated with subcutaneous ofatumumab. Frontiers in immunology. vol 14. 2023-08-31. PMID:37649484. |
the phenotypic spectrum of myelin oligodendrocyte glycoprotein (mog)- igg-associated disorders (mogad) has broadened in the past few years, and atypical phenotypes are increasingly recognized. |
2023-08-31 |
2023-09-07 |
Not clear |
| Kota Moriguchi, Yumina Nakamura, Ah-Mee Park, Fumitaka Sato, Motoi Kuwahara, Sundar Khadka, Seiichi Omura, Ijaz Ahmad, Susumu Kusunoki, Ikuo Tsunod. Anti-Glycolipid Antibody Examination in Five EAE Models and Theiler's Virus Model of Multiple Sclerosis: Detection of Anti-GM1, GM3, GM4, and Sulfatide Antibodies in Relapsing-Remitting EAE. International journal of molecular sciences. vol 24. issue 16. 2023-08-26. PMID:37629117. |
using three mouse strains, sjl/j, c57bl/6, and a.sw mice, we induced five distinct experimental autoimmune encephalomyelitis (eae) models with myelin oligodendrocyte glycoprotein (mog) |
2023-08-26 |
2023-09-07 |
mouse |
| Xuechun Chang, Kexin Jiao, Danjie Wang, Yufan Zhou, Zhao Zhao, Ying Xing, Jingzi Zhangbao, Chuanzhen Lu, Jun Wang, Chao Qua. The immune imbalance between follicular regulatory and helper T cells in myelin oligodendrocyte glycoprotein IgG-associated disease. Clinical immunology (Orlando, Fla.). 2023-08-12. PMID:37572951. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is a newly defined inflammatory demyelinating disease of the central nervous system. |
2023-08-12 |
2023-08-16 |
Not clear |
| Charlotta Hansson, Cristina Lebrero-Fernández, Karin Schön, Davide Angeletti, Nils Lyck. Tr1 cell-mediated protection against autoimmune disease by intranasal administration of a fusion protein targeting cDC1 cells. Mucosal immunology. vol 16. issue 4. 2023-08-11. PMID:37192682. |
the cta1 r7k mutant - myelin oligodendrocyte glycoprotein (mog), or proteolipid protein (plp) - dd (cta1r7k-mog/plp-dd) fusion proteins effectively reduced clinical symptoms in the experimental autoimmune encephalitis model of multiple sclerosis. |
2023-08-11 |
2023-08-16 |
Not clear |
| D D Eliseeva, A K Kalashnikova, V V Bryukhov, N A Andreeva, N V Zhorzholadze, Yu K Murakhovskaya, T D Krilova, P G Tsygankova, M N Zakharova, N L Shereme. [Hereditary optic neuropathy associated with demyelinating diseases of the central nervous system]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 123. issue 7. Vyp. 2. 2023-08-10. PMID:37560844. |
optic neuritis can occur at the onset or be one of the syndromes within multiple sclerosis (ms), neuromyelitis optica spectrum disorders (nmosd), and myelin oligodendrocyte glycoprotein (mog) antibody disease (mogad). |
2023-08-10 |
2023-08-16 |
Not clear |
| Yoshiki Takai, Tatsuro Misu, Kazuo Fujihara, Masashi Aok. Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders. Frontiers in neurology. vol 14. 2023-08-07. PMID:37545724. |
myelin oligodendrocyte glycoprotein (mog) is expressed on the outermost layer of the myelin sheath in the central nervous system. |
2023-08-07 |
2023-08-14 |
human |
| b' Luciana Midaglia, Ana Felipe-Ruci\\xc3\\xa1n, Ignacio Delgado Alvarez, Xavier Montalban, Mar Tintor\\xc3\\xa. Diagnostic challenge in children with an acquired demyelinating syndrome: an illustrative case report. Frontiers in neuroscience. vol 17. 2023-08-07. PMID:37547139.' |
anti myelin oligodendrocyte glycoprotein (mog) antibodies (abs) were positive in cerebrospinal fluid (csf) and weakly in serum. |
2023-08-07 |
2023-08-14 |
Not clear |
| Ana Beatriz Ayroza Galvão Ribeiro Gomes, Laila Kulsvehagen, Patrick Lipps, Alessandro Cagol, Nuria Cerdá-Fuertes, Tradite Neziraj, Julia Flammer, Jasmine Lerner, Anne-Catherine Lecourt, Nina de Oliveira S Siebenborn, Rosa Cortese, Sabine Schaedelin, Vinicius Andreoli Schoeps, Aline de Moura Brasil Matos, Natalia Trombini Mendes, Clarissa Dos Reis Pereira, Mario Luiz Ribeiro Monteiro, Samira Luisa Dos Apóstolos-Pereira, Patrick Schindler, Claudia Chien, Carolin Schwake, Ruth Schneider, Thivya Pakeerathan, Orhan Aktas, Urs Fischer, Matthias Mehling, Tobias Derfuss, Ludwig Kappos, Ilya Ayzenberg, Marius Ringelstein, Friedemann Paul, Dagoberto Callegaro, Jens Kuhle, Athina Papadopoulou, Cristina Granziera, Anne-Katrin Pröbste. Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients With Central Nervous System Demyelination. JAMA neurology. 2023-08-07. PMID:37548987. |
yet little is known about the presence and clinical relevance of iga antibodies against myelin oligodendrocyte glycoprotein (mog) in cns demyelination. |
2023-08-07 |
2023-08-14 |
Not clear |
| Varun Kannan, Alexander J Sandweiss, Timothy A Erickson, Jonathan M Yarimi, Alexander Ankar, Victoria A Hardwick, Nikita M Shukla, Timothy E Lotze, Sarah R Risen, James J Riviello, Yi-Chen Lai, Karen K Moeller, Kristen Fishe. Fulminant Anti-Myelin Oligodendrocyte Glycoprotein-Associated Cerebral Cortical Encephalitis: Case Series of a Severe Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Phenotype. Pediatric neurology. vol 147. 2023-08-06. PMID:37544084. |
we describe a cohort of children with severe myelin oligodendrocyte glycoprotein (mog)-igg-associated cerebral cortical encephalitis (cce), manifesting with bilateral cortical cytotoxic edema and critical neurological illness. |
2023-08-06 |
2023-08-14 |
Not clear |
| Jessica A Kraker, John J Che. An update on optic neuritis. Journal of neurology. 2023-08-05. PMID:37542657. |
although most cases of optic neuritis (on) are classified as typical, meaning idiopathic or associated with multiple sclerosis, there is a growing understanding of atypical forms of optic neuritis such as antibody mediated aquaporin-4 (aqp4)-igg neuromyelitis optica spectrum disorder (nmosd) and the recently described entity, myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad). |
2023-08-05 |
2023-08-14 |
Not clear |
| Yoav Shulman, Lena Finkelstein, Yakir Levi, Dimitry Kovalchuk, Ayelet Weksler, Alejandro Reichstein, Keren Kigel-Zur, Mazal Davidi, Isaac Levi, Avital Schauder, Keren Rubin, Elhanan Achituv, David Castel, Sigal Meili. A novel sensory wave (P25) in MOG-induced EAE murine model. The journal of pain. 2023-07-31. PMID:37524220. |
myelin oligodendrocyte glycoprotein (mog)-induced experimental autoimmune encephalomyelitis (eae) is a murine model for multiple sclerosis (ms). |
2023-07-31 |
2023-08-14 |
mouse |
| Tammy L Smith, Thomas R Haven, Lauren M Zuromski, Kyphuong Luong, Stacey L Clardy, Lisa K Peterso. High level of agreement in a fixed vs. live cell-based assay for antibodies to myelin oligodendrocyte glycoprotein in a real-world clinical laboratory setting. Frontiers in neurology. vol 14. 2023-07-28. PMID:37503513. |
as recognition of myelin oligodendrocyte glycoprotein (mog) antibody-associated disease becomes more widespread, the importance of appropriately ordering and interpreting diagnostic testing for this antibody increases. |
2023-07-28 |
2023-08-14 |
Not clear |
| Giulia Fadda, Alonso Cardenas de la Parra, Julia O'Mahony, Patrick Waters, E Ann Yeh, Amit Bar-Or, Ruth Ann Marrie, Sridar Narayanan, Douglas L Arnold, D Louis Collins, Brenda Banwel. Deviation From Normative Whole Brain and Deep Gray Matter Growth in Children With MOGAD, MS, and Monophasic Seronegative Demyelination. Neurology. vol 101. issue 4. 2023-07-26. PMID:37258297. |
pediatric-acquired demyelination of the cns associated with antibodies directed against myelin oligodendrocyte glycoprotein (mog; mog antibody-associated disease [mogad]) occurs as a monophasic or relapsing disease and with variable but often extensive t2 lesions in the brain. |
2023-07-26 |
2023-09-07 |
Not clear |
| Yoonkyung Lee, Seon-Jae Ahn, Han-Sang Lee, Yongmoo Kim, Seolah Lee, Hyeyoung Park, Jangsup Moon, Sang Kun Lee, Kon Ch. Myelin oligodendrocyte glycoprotein antibody-associated encephalitis after severe acute respiratory syndrome coronavirus 2 infection: a case report and retrospective case reviews. Encephalitis (Seoul, Korea). vol 3. issue 2. 2023-07-20. PMID:37469677. |
several cases of myelin oligodendrocyte glycoprotein (mog) antibody-associated encephalitis have been reported after coronavirus disease 2019 (covid-19). |
2023-07-20 |
2023-08-14 |
Not clear |
| Hansol Im, Taewon Ki. New-onset epilepsy in a patient with myelin oligodendrocyte glycoprotein antibodies. Encephalitis (Seoul, Korea). vol 1. issue 2. 2023-07-20. PMID:37469761. |
in the literature, several adult cases with myelin oligodendrocyte glycoprotein (mog) antibodies (abs)-associated disorders have been reported to have seizure and acute disseminated encephalomyelitis (adem) as the main clinical manifestations, but the number is somewhat low. |
2023-07-20 |
2023-08-14 |
Not clear |
| Naoki Takegami, Hiroyuki Murai, Harushi Mori, Nanaka Yamaguchi-Takegami, Tatsushi Toda, Nobue K Iwata, Jun Got. Multiple cortical lesions with grainy enhancement of magnetic resonance imaging in anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated encephalitis with seizures (FLAMES). Journal of the neurological sciences. vol 451. 2023-07-20. PMID:37473617. |
multiple cortical lesions with grainy enhancement of magnetic resonance imaging in anti-myelin oligodendrocyte glycoprotein (mog) antibody-associated encephalitis with seizures (flames). |
2023-07-20 |
2023-08-14 |
Not clear |
| Mellad M Khoshnood, Jonathan D Santor. Myelin Oligodendrocyte Glycoprotein (MOG) Associated Diseases: Updates in Pediatric Practice. Seminars in pediatric neurology. vol 46. 2023-07-14. PMID:37451753. |
myelin oligodendrocyte glycoprotein (mog) associated diseases: updates in pediatric practice. |
2023-07-14 |
2023-08-14 |
Not clear |
| Mellad M Khoshnood, Jonathan D Santor. Myelin Oligodendrocyte Glycoprotein (MOG) Associated Diseases: Updates in Pediatric Practice. Seminars in pediatric neurology. vol 46. 2023-07-14. PMID:37451753. |
myelin oligodendrocyte glycoprotein (mog) is a membrane bound protein found on the surface of oligodendrocyte cells and the outermost surface of myelin sheaths. |
2023-07-14 |
2023-08-14 |
Not clear |